Neurofibromatosis 1 French national guidelines based on an extensive literature review since 1966

C Bergqvist, A Servy, L Valeyrie-Allanore… - Orphanet Journal of …, 2020 - Springer
Neurofibromatosis type 1 is a relatively common genetic disease, with a prevalence ranging
between 1/3000 and 1/6000 people worldwide. The disease affects multiple systems with …

Guidelines for the diagnosis and management of individuals with neurofibromatosis 1

RE Ferner, SM Huson, N Thomas, C Moss… - Journal of medical …, 2007 - jmg.bmj.com
Neurofibromatosis 1 (NF1) is a common neurocutaneous condition with an autosomal
dominant pattern of inheritance. The complications are diverse and disease expression …

Genotype-phenotype correlation in NF1: evidence for a more severe phenotype associated with missense mutations affecting NF1 codons 844–848

M Koczkowska, Y Chen, T Callens, A Gomes… - The American Journal of …, 2018 - cell.com
Neurofibromatosis type 1 (NF1), a common genetic disorder with a birth incidence of 1:
2,000–3,000, is characterized by a highly variable clinical presentation. To date, only two …

High incidence of Noonan syndrome features including short stature and pulmonic stenosis in patients carrying NF1 missense mutations affecting p. Arg1809 …

K Rojnueangnit, J Xie, A Gomes, A Sharp… - Human …, 2015 - Wiley Online Library
ABSTRACT Neurofibromatosis type 1 (NF1) is one of the most frequent genetic disorders,
affecting 1: 3,000 worldwide. Identification of genotype–phenotype correlations is …

An absence of cutaneous neurofibromas associated with a 3-bp inframe deletion in exon 17 of the NF1 gene (c. 2970-2972 delAAT): evidence of a clinically significant …

M Upadhyaya, SM Huson, M Davies, N Thomas… - The American Journal of …, 2007 - cell.com
Neurofibromatosis type 1 (NF1) is characterized by café-au-lait spots, skinfold freckling, and
cutaneous neurofibromas. No obvious relationships between small mutations (< 20 bp) of …

Prevalence of neurofibromatosis type 1 in the Finnish population

RA Kallionpää, E Uusitalo, J Leppävirta… - Genetics in …, 2018 - nature.com
Purpose The incidence of neurofibromatosis 1 (NF1) is~ 1/2,000 live births, but the current
estimates of prevalence vary greatly. This retrospective total-population study was aimed at …

Association between benign and malignant peripheral nerve sheath tumors in NF1

T Tucker, P Wolkenstein, J Revuz, J Zeller… - Neurology, 2005 - AAN Enterprises
Objective: People with neurofibromatosis type 1 (NF1) have a 10% lifetime risk of
developing a malignant peripheral nerve sheath tumor (MPNST). MPNSTs are often …

Neuropathic pruritus

L Misery, E Brenaut, R Le Garrec, C Abasq… - Nature reviews …, 2014 - nature.com
Pruritus, also known as itch, is a very common, unpleasant sensation that elicits an urge to
scratch. Its origin is not always in the skin, and neuropathic itch that is caused by neuronal or …

Clinical spectrum of individuals with pathogenic NF1 missense variants affecting p.Met1149, p.Arg1276, and p.Lys1423: genotype–phenotype study in …

M Koczkowska, T Callens, Y Chen, A Gomes… - Human …, 2020 - Wiley Online Library
We report 281 individuals carrying a pathogenic recurrent NF1 missense variant at p.
Met1149, p. Arg1276, or p. Lys1423, representing three nontruncating NF1 hotspots in the …

Assessment of benign tumor burden by whole-body MRI in patients with neurofibromatosis 1

VF Mautner, FA Asuagbor, E Dombi… - Neuro …, 2008 - academic.oup.com
Abstract People with neurofibromatosis 1 (NF1) have multiple benign neurofibromas and a
10% lifetime risk of developing malignant peripheral nerve sheath tumors (MPNSTs). Most …